Phytotherapy Research, 23(3), 367-372
Eleven brands across six molecules, made almost entirely by two companies Novo Nordisk and Eli Lilly: Semaglutide (Novo Nordisk) Ozempic, Wegovy, Rybelsus Tirzepatide (Eli Lilly) Mounjaro, Zepbound Liraglutide (Novo Nordisk) Victoza, Saxenda Dulaglutide (Eli Lilly) Trulicity Exenatide (AstraZeneca) Byetta, Bydureon BCise Lixisenatide (Sanofi) Adlyxin, no longer marketed in the US For weight management , the FDA has approved Wegovy, Zepbound and Saxenda
This makes it a promising prospect to use in treatment in the future
An international multicenter trial is currently underway to validate the effects of GLP-1R activation in active IIH (NCT05347147)
### Precautions: Consult A Healthcare Professional Before Use, Especially If You Have Underlying Medical Conditions Or Are Taking Other Medications